NEXENTIS TECHNOLOGIES INC. Other Current Liabilities
NEXENTIS TECHNOLOGIES INC. (NXTS) had Other Current Liabilities of $2.55 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Other Liabilities, Current $2.55M.
- 2026-03-31: Other Liabilities, Current $1.32M.
- 2025-12-31: Other Liabilities, Current $416.00K.
- 2025-09-30: Other Liabilities, Current $728.00K.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $2.55M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $1.32M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $416.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $728.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $623.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $531.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $266.00K 10-K · filed 2026-03-31 | $532.00K 10-K · filed 2025-03-31 |
| 2024-09-30 | $484.59K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $365.76K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $399.15K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $735.00K 10-K · filed 2025-03-31 | $734.93K 10-K · filed 2024-04-01 |
| 2023-09-30 | $217.64K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $195.22K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $273.56K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $587.37K 10-K · filed 2024-04-01 | $295.04K 10-K · filed 2023-03-27 |
| 2022-09-30 | $315.77K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $289.44K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $395.75K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $383.55K 10-K · filed 2023-03-27 | |
| 2021-09-30 | $593.14K 10-Q · filed 2021-11-15 | |
| 2020-12-31 | $517.71K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |